A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction

Patients entrolled in the Thrombolysis In Myocardial Infarction 11B trial were stratified into low-, intermediate-, and high-risk groups based on the number of the criteria of age ==>65 years, ST-segment deviation, or serum cardiac enzyme elevation. The primary end point of death, myocardial infa...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2001-04, Vol.87 (8), p.1008-1010
Main Authors: Holper, Elizabeth M., Antman, Elliott M., McCabe, Carolyn H., Premmereur, Jerome, Gurfinkel, Enrique, Bernink, Peter J.L.M., Turpie, Alexander G., Bayes de Luna, Antonio, Lablanche, Jean-Marc, Fox, Kim M., Salein, Diana, Radley, David R., Braunwald, Eugene
Format: Article
Language:English
Subjects:
Aged
Angina pectoris
Angina, Unstable - drug therapy
Anticoagulants - therapeutic use
Biological and medical sciences
Cardiology. Vascular system
Cardiovascular disease
Chi-Square Distribution
Coronary heart disease
Enoxaparin - therapeutic use
Female
Heart
Heart attacks
Heparin - therapeutic use
Humans
Male
Medical research
Medical sciences
Myocardial Infarction - drug therapy
Myocardial Revascularization
Randomized Controlled Trials as Topic
Risk assessment
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients entrolled in the Thrombolysis In Myocardial Infarction 11B trial were stratified into low-, intermediate-, and high-risk groups based on the number of the criteria of age ==>65 years, ST-segment deviation, or serum cardiac enzyme elevation. The primary end point of death, myocardial infarction, and severe recurrent ischemia through day 43 occurred in 14.5%, 19.3%, and 27.3% in the low-, intermediate-, and high-risk groups, respectively (p
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(01)01440-0